Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of Baidu.com, Inc. (ADR) (BIDU)?

Page 1 of 2

Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the third quarter. Among them, Valeant and Micron ranked among the top 30 picks and both lost around 20%. Citigroup, which was the third most popular stock, lost 10% amid uncertainty regarding the interest rates. Nevertheless, our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted returns. This is why following the smart money sentiment is a useful tool at identifying the next stock to invest in.

Baidu.com, Inc. (ADR) (NASDAQ:BIDU) was in 52 hedge funds’ portfolios at the end of the third quarter of 2015. BIDU shareholders have witnessed a decrease in hedge fund sentiment lately. There were 70 hedge funds in our database with BIDU holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Regeneron Pharmaceuticals Inc (NASDAQ:REGN), The TJX Companies, Inc. (NYSE:TJX), and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) to gather more data points.

Follow Baidu Inc (NASDAQ:BIDU)
Trade (NASDAQ:BIDU) Now!

Keeping this in mind, we’re going to review the latest action surrounding Baidu.com, Inc. (ADR) (NASDAQ:BIDU).

How have hedgies been trading Baidu.com, Inc. (ADR) (NASDAQ:BIDU)?

At the end of the third quarter, a total of 52 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -26% from one quarter earlier. With the smart money’s sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their stakes significantly (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Scopia Capital, managed by Matt Sirovich and Jeremy Mindich, holds the largest position in Baidu.com, Inc. (ADR) (NASDAQ:BIDU). Scopia Capital has a $377.2 million position in the stock, comprising 8.1% of its 13F portfolio. On Scopia Capital’s heels is Cantillon Capital Management, led by William von Mueffling, holding a $304.7 million position; 6.5% of its 13F portfolio is allocated to the stock. Remaining peers that are bullish comprise William B. Gray’s Orbis Investment Management, Ricky Sandler’s Eminence Capital and Kerr Neilson’s Platinum Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!